Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Acadia Healthcare Company (ACHC) over the last 15 years, with Q3 2025 value amounting to $395416.0.

  • Acadia Healthcare Company's Non-cash Items fell 9496.16% to $395416.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $395416.0, marking a year-over-year decrease of 9496.16%. This contributed to the annual value of $393416.0 for FY2024, which is 1270.08% up from last year.
  • As of Q3 2025, Acadia Healthcare Company's Non-cash Items stood at $395416.0, which was down 9496.16% from $422610.0 recorded in Q2 2025.
  • In the past 5 years, Acadia Healthcare Company's Non-cash Items ranged from a high of $128.4 million in Q1 2025 and a low of $323137.0 during Q3 2022
  • In the last 5 years, Acadia Healthcare Company's Non-cash Items had a median value of $7.8 million in 2024 and averaged $16.6 million.
  • Over the last 5 years, Acadia Healthcare Company's Non-cash Items had its largest YoY gain of 634154.03% in 2023, and its largest YoY loss of 9901.12% in 2023.
  • Acadia Healthcare Company's Non-cash Items (Quarter) stood at $20.0 million in 2021, then skyrocketed by 76.62% to $35.3 million in 2022, then tumbled by 99.01% to $349080.0 in 2023, then rose by 12.7% to $393416.0 in 2024, then rose by 0.51% to $395416.0 in 2025.
  • Its last three reported values are $395416.0 in Q3 2025, $422610.0 for Q2 2025, and $128.4 million during Q1 2025.